To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
23 Newest Market Studies about the topic gastric cancer
rss
Gastric Cancer - Germany Drug Forecasts and Treatment Analysis to 2020
Introduction Global Data, the industry analysis specialist, has released its new report, “Gastric Cancer - Germany Drug Forecasts and Treatment Analysis to 2020”. The report is an essential source of information and analysis on the Germany gastric cancer therapeutics market. The report ...
Gastric Cancer - France Drug Forecasts and Treatment Analysis to 2020
Introduction Global Data, the industry analysis specialist, has released its new report, “Gastric Cancer - France Drug Forecasts and Treatment Analysis to 2020”. The report is an essential source of information and analysis on the France gastric cancer therapeutics market. The report ...
Pacific Edge Limited (PEB) - Financial and Strategic SWOT Analysis Review
Pacific Edge Limited (PEB) - Financial and Strategic SWOT Analysis Review Summary Pacific Edge Limited (PEB), formerly Pacific Edge Biotechnology Limited is a biomedical company engaged in the discovery and commercialization of diagnostic and prognostic products for human cancer. The ...
Tularik, Inc. (TLRK) - Strategic SWOT Analysis Review
Tularik, Inc. (Tularik) is a pharmaceutical company that is engaged in the discovery and development of oral medicines. The products offered by the company act through the regulation of gene expression. The company is focused on the development of drugs for the treatment of esophageal cancer, ...
NanoCarrier Co., Ltd. (4571) - Financial and Strategic SWOT Analysis Review
NanoCarrier Co., Ltd. (NanoCarrier) is a biotechnology company, engaged in the research, development and manufacturing of anticancer drugs using micellar nanoparticles technology. The company principally concentrates to develop drugs in the field of oncology. The product pipeline of the ...
YM BioSciences Inc. (YM) - Financial and Strategic SWOT Analysis Review
YM BioSciences Inc. (YM BioSciences) is a publicly held Canada-based company. The company is principally engaged in the development of products for the life sciences markets. The product portfolio includes oncology products which are at various stages of development. It is engaged in the ...
Miraculins Inc. (MOM) - Strategic SWOT Analysis Review
Miraculins Inc (Miraculins) is a research and development company engaged in the discovery and validation of cancer biomarkers, which enable the development of diagnostic tools and therapeutic products. The company focuses on biomarker discovery using its proprietary B.E.S.T Platform for the ...
Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market
Introduction Avastin (bevacizumab) is a vascular endothelial growth factor (VEGF) receptor inhibitor. It was first approved in 2004 and is used in the treatment of various cancers. At present, it is approved for the late-stage treatment of colorectal cancer, non-small cell lung cancer ...
Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 – Volume I 2011
Introduction GlobalData, the industry analysis specialist, has released its new report, “Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 – Volume I 2011”. The report is an essential source of information and analysis on the global gastric cancer therapeutics market. ...
Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 Volume I 2011
Introduction GlobalData, the industry analysis specialist, has released its new report, Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 Volume I 2011. The report is an essential source of information and analysis on the global gastric cancer therapeutics market. ...
Netmeeting
